Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Stretches California Footprint, Reaches Hawaii With Longs Buy

This article was originally published in The Tan Sheet

Executive Summary

CVS/Caremark is gaining a retail pharmacy presence in major new markets in California and other western states through its acquisition of Longs

You may also be interested in...



CVS closes Longs deal, reports OTC growth

CVS/Caremark announces Oct. 30 the finalization of its acquisition of Longs Drug Stores Corp., which has 521 locations in markets mostly without a CVS presence, including Hawaii and central and northern California (1"The Tan Sheet" Aug. 18, 2008, p. 19). CVS/Caremark President and CEO Tom Ryan says the deal "accelerates our expansion into key growth markets." The Woonsocket, R.I.-based firm also reports third quarter retail sales of $11.5 billion, a 5.3 percent jump. Ryan says the cough/cold business "is up double-digit year-to-date" and the OTC health care category and private-label sales are up. He attributes the increases to "economic step therapy," in which consumers self-medicate before seeking costlier health care

CVS closes Longs deal, reports OTC growth

CVS/Caremark announces Oct. 30 the finalization of its acquisition of Longs Drug Stores Corp., which has 521 locations in markets mostly without a CVS presence, including Hawaii and central and northern California (1"The Tan Sheet" Aug. 18, 2008, p. 19). CVS/Caremark President and CEO Tom Ryan says the deal "accelerates our expansion into key growth markets." The Woonsocket, R.I.-based firm also reports third quarter retail sales of $11.5 billion, a 5.3 percent jump. Ryan says the cough/cold business "is up double-digit year-to-date" and the OTC health care category and private-label sales are up. He attributes the increases to "economic step therapy," in which consumers self-medicate before seeking costlier health care

CVS closes Longs deal, reports OTC growth

CVS/Caremark announces Oct. 30 the finalization of its acquisition of Longs Drug Stores Corp., which has 521 locations in markets mostly without a CVS presence, including Hawaii and central and northern California (1"The Tan Sheet" Aug. 18, 2008, p. 19). CVS/Caremark President and CEO Tom Ryan says the deal "accelerates our expansion into key growth markets." The Woonsocket, R.I.-based firm also reports third quarter retail sales of $11.5 billion, a 5.3 percent jump. Ryan says the cough/cold business "is up double-digit year-to-date" and the OTC health care category and private-label sales are up. He attributes the increases to "economic step therapy," in which consumers self-medicate before seeking costlier health care

Related Content

Topics

UsernamePublicRestriction

Register

SC142962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel